Prevalence of HBV in Pregnancy - Trial NCT05442372
Access comprehensive clinical trial information for NCT05442372 through Pure Global AI's free database. This phase not specified trial is sponsored by Sohag University and is currently Recruiting. The study focuses on Hepatitis B. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Sohag University
Timeline & Enrollment
N/A
Jun 15, 2022
Dec 15, 2022
Primary Outcome
HBsAg,Risk factors of HBV in pregnancy
Summary
The most common mode of HBV transmission is materno-fetal transmission mainly during labor.
 This study aims to estimate the seroprevalence of HBV infection and the possible risk factors
 of HBV acquisition in pregnant women in Upper Egypt and to evaluate the predictive value of
 HBeAg and quantitative HBsAg as surrogate markers for high viremia in pregnant women.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05442372
Non-Device Trial